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a  b  s  t  r  a  c  t
Contagious  bovine  pleuropneumonia  (CBPP)  is  an  economically  important  trans-boundary
cattle  disease  which  affects  food  security  and  livelihoods.  A conjoint  analysis–contingent
valuation  was  carried  out  on  190  households  in Narok  South  District  of Kenya  to  measure
willingness  to pay  (WTP)  and  demand  for CBPP  vaccine  and  vaccination  as  well  as  factors
affecting  WTP.  The  mean  WTP  was  calculated  at Kenya  Shillings  (KSh)  212.48  (USD  3.03)
for  vaccination  using  a vaccine  with  the  characteristics  that  were  preferred  by the  farmers
(preferred  vaccine  and  vaccination)  and  KSh  −71.45  (USD  −1.02) for  the  currently  used  vac-
cine and  vaccination.  The  proportion  of  farmers  willing  to  pay  an  amount  greater  than  zero
was 66.7%  and  34.4%  for the  preferred  and  current  vaccine  and  vaccination  respectively.
About  one  third  (33.3%)  of farmers  would  need  to be compensated  an  average  amount  of
KSh 1162.62  (USD  13.68)  per  animal  to  allow  their  cattle  to be vaccinated  against  CBPP  using
the  preferred  vaccine  and  vaccination.  About  two-thirds  (65.6%)  of  farmers  would  need  to
be compensated  an  average  amount  of  KSh 853.72  (USD  12.20)  per  animal  to allow  their
cattle  to be vaccinated  against  CBPP  using  the  current  vaccine  and  vaccination.  The  total
amount  of  compensation  would  be  KSh  61.39  million  (USD  0.88  million)  for  the  preferred
vaccine  and vaccination  and  KSh  90.15  million  (USD  1.29  million)  for  the  current  vaccine
and  vaccination.  Demand  curves  drawn  from  individual  WTP  demonstrated  that  only  59%
and 27% of cattle  owners  with  a  WTP  greater  than  zero  were  willing  to pay  a benchmark
cost  of KSh  34.60  for the  preferred  and  current  vaccine  respectively.  WTP  was  negatively
inﬂuenced  by the attitude  about  household  economic  situation  (p = 0.0078),  presence  of
cross breeds  in  the  herd  (p < 0.0001)  and  years  since  CBPP  had  been  experienced  in  the  herd
(p = 0.0375).  It  was  positively  inﬂuenced  by education  (p =  0.0251)  and  the  practice  of treat-
ing against  CBPP  (p = 0.0432).  The  beneﬁt  cost  ratio (BCR)  for  CBPP  vaccination  was  2.9–6.1
depending  on  the  vaccination  programme.  In  conclusion,  although  a proportion  of  farm-
ers was  willing  to pay,  participation  levels  may  be lower  than  those  required  to interrupt
transmission  of  CBPP.  Households  with  characteristics  that  inﬂuence  WTP  negatively  need
persuasion  to  participate  in  CBPP  vaccination.  It is  economically  worthwhile  to vaccinate
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00625,  Nairobi. Tel.: +254 0722 568 510.
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against  CBPP.  A beneﬁt  cost  analysis  (BCA)  using  aggregated  WTP  as beneﬁts  can  be used
as  an  alternative  method  to  the  traditional  BCA  which  uses  avoided  production  losses  (new
revenue)  and  costs  saved  as beneﬁts.
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. Introduction
Contagious bovine pleuropneumonia (CBPP) in Africa
s an important trans-boundary animal disease due to the
igh mortalities and productivity losses its causes as well
s its threat to food security and access to markets (Paskin,
003). Its annual economic costs in 12 sub-Saharan African
ountries have been estimated at 44.8 million Euros (Tambi
t al., 2006). About 24.4 million people in 19 sub-Saharan
frican countries, including 1.3 million in Kenya, are at risk
f livestock losses caused by CBPP and 30–50% of these
eople are living below poverty levels (Thomson, 2005).
The existing sub-Saharan policy on CBPP control is based
n the strategy proposed following observations recorded
n the Mara in Kenya and Tanzania. It recommends move-
ent control, quarantine, test and slaughter policy and
accination with T1 vaccines. Complete (100%) and reg-
lar vaccination for at least ﬁve consecutive years with
epeat (biannual) vaccination was recommended by the
ost Pan-African rinderpest campaign (PARC) report (OAU-
BAR, 1999) and re-afﬁrmed at successive regional CBPP
orkshops (AU/IBAR, 2004). The recommendation by OAU-
BAR (1999) aimed at eradication of CBPP. However, due
o socio-economic and socio-cultural reasons, control of
mpact of the disease needs to be the immediate objec-
ive rather than eradication, although eradication at zonal
r country level as a long term goal must be kept in sight
AU-IBAR, 2004).
Cattle movement control is difﬁcult to implement in
astoral production systems because of transhumance and
ocio-cultural practices. It is also difﬁcult where there is
ivil strife and cattle rustling (Masiga et al., 1998). Test
nd slaughter fails in most African countries because of
he reluctance of owners to slaughter their animals and
f governments to pay compensation (Thomson, 2005).
ntimicrobial treatment against CBPP is still ofﬁcially
iscouraged (FAO, 2007) although it is under research.
tamping out is difﬁcult to implement and has far reach-
ng socio-economic effects (Mullins et al., 2000). Cognizant
f the aforementioned shortcomings associated with other
ontrol methods, vaccination remains the most preferred
ontrol method in the African region. However, vaccina-
ions throughout the region are irregular and coverage is
ow (Wanyoike, 1999). This is probably due to the fact
hat national mass vaccination campaigns against CBPP are
xpensive and often beyond the budget of most African
ountries (Thomson, 2005). A minimum coverage of 80%
wice a year is required in order for herd immunity to reach
0% and this must be maintained at above 80% in order to
nterrupt disease transmission (Mariner and Catley, 2004).
his requires a good vaccine, adequate funds and appropri-
te policies and practices in delivery of the vaccine as well
s cooperation by the farmers (McLeod and Rushton, 2007).
t is suggested that in countries where CBPP vaccination islished  by  Elsevier  B.V.  This  is an  open  access  article  under  the  CC
D  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
conducted by the government, vaccination should be elec-
tive and can be sub-contracted to the private sector with
the government facilitating the supply of the vaccine and
enacting enabling legislation in order to reach the appro-
priate vaccination coverage (Mariner et al., 2006).
Although T1 vaccine is the recommended vaccine
against CBPP, its stability after reconstitution in a thermo-
labile environment is only up to 2 h and there is no way
of visually assessing its viability (March, 2004). Further,
although adverse reactions are less than with the earlier
vaccines, T1 vaccine continues to elicit adverse reactions
in 1–5% of vaccinated cattle (Thiaucourt et al., 2004). The
vaccine also elicits poor efﬁcacy of only 65% in a single vac-
cination although it can increase to 95.5% in revaccination
after 6 months. It also confers immunity for 6–12 months
(Wesonga and Thiaucourt, 2000; Nkando et al., 2011).
In some countries, vaccination costs have been par-
tially recovered from cattle owners (Twinamasiko, 2002).
However, introduction of full scale cost recovery or pri-
vatization of vaccination against CBPP may  lead to further
reductions in vaccination coverage especially if the vaccine
has shortcomings and in the absence of outbreaks (McLeod
and Wilsmore, 2002). In Kenya, although cost recovery
has been introduced for some vaccinations, CBPP vaccina-
tion remains government controlled and is free of charge
particularly in pastoralist areas (Kajume, 1999) although
commercial farms may  purchase the vaccine and vacci-
nate under supervision. Privatization of services is hard to
implement in pastoral areas yet this is where CBPP is more
prevalent (Woodford, 2004; Wanyoike, 2009). McLeod and
Wilsmore (2002) observe that there may  be market failure
and subsequent low adoption if service delivery of a pub-
lic good is performed by the private sector unless there is
subsidization.
In spite of the fact that participation in CBPP vaccina-
tion can be pegged to farmers’ willingness to pay (WTP)
(Thomson, 2005), no study has been carried out to inves-
tigate this. The purpose of this study seeks to close this
information gap, and to provide a monetary estimate of
what livestock farmers in Narok district of Kenya are will-
ing to pay to participate in a CBPP vaccination programme.
This study was  part of a project aimed at comparing the
safety and efﬁcacy of the currently used CBPP vaccine
and one improved in stability by including a buffer in
the mycoplasma growth medium (March, 2004) and is an
extension of a study on farmer preferences for CBPP vaccine
and vaccination (Kairu-Wanyoike et al., 2013).
Willingness to pay for a good or service or both can be
quantiﬁed using contingent valuation method (CVM) either
directly using revealed preference formats or indirectly
using stated preference formats (Brown, 2005). Conjoint
analysis (CJA) is a stated preference format which requires
the good and/or service to be ﬁrst split into its various com-
ponents (attributes). Different levels of attributes of the
ive Veter132 S.W. Kairu-Wanyoike et al. / Prevent
good or service are combined to form proﬁles. The pro-
ﬁles can also incorporate some hypothetical but realistic
attributes which are required to be included in a good or
service under development (Mitchell and Carson, 1989).
The consumer then values a reduced number of proﬁles by
ranking or rating with the latter giving more power dur-
ing statistical analysis (Sayadi et al., 2005). A regression
model is then applied to obtain attribute parameter esti-
mates (  ˇ coefﬁcients) and therefore preference levels for
each attribute. If price is included as one of the attributes,
the utility estimates can then be used to calculate WTP  ﬁrst
for the other attributes as −ˇj/ˇp where j is an attribute and
p is price and then for the proﬁle by adding up the WTPs
for the individual attributes (Sayadi et al., 2009). When
used this way, the technique is termed conjoint analysis–
contingent valuation method (CJA–CVM) and can be used
to obtain ﬁrst preferences and then WTP  for a good or
service.
This paper reports on the ﬁndings of a study designed to
measure WTP  or compensation for CBPP vaccine and vac-
cination as well as factors affecting WTP  in 190 households
in Narok South District of Kenya.
2. Materials and methods
2.1. Selection study area
The study was carried out in the Mara and Loita divisions
of Narok district of Kenya (Fig. 1). These divisions were
selected because of the high incidence of reported out-
breaks of CBPP. Indeed 11 out of the 16 (68.8%) conﬁrmed
outbreaks reported countrywide in the last 5 years prior to
the study were from this part of the district (Wanyoike,
2009). In addition, livestock farmers in these divisions
are familiar with the disease and its control methods and
vaccination in particular (Wanyoike, 1999). Further, there
is need for cooperation between Kenya and Tanzania in
CBPP control as the disease exists in the cattle belong-
ing to the Maasai communities residing on both sides
of the Kenya–Tanzania border. Mara and Loita divisions
are in Southern Kenya, bordering the area in Tanzania
where CBPP exists and were therefore suitable areas for the
study.
2.2. Description of the study area
Narok South District is part of the Arid and Semi-Arid
Lands (ASALs) of Kenya. While Mara division is charac-
terized by lowland grasslands, there are a few highland
areas in Loita division. The district is inhabited mainly by
Maasai pastoralists. The traditional Maasai homestead or
boma belongs to one or more families. The main cattle pro-
duction systems are pastoralism and agro-pastoralism, the
main cattle breed kept being Zebu. Other economic activi-
ties are tourism and wildlife related activities principally in
Mara division (Thompson and Homewood, 2002). CBPP is
endemic in both divisions due to communal grazing and
watering of cattle as well as congregation of animals at
night in a central cattle holding area. Livestock cross the
Kenya–Tanzania border in search of pastures and for tradeinary Medicine 115 (2014) 130–142
leading to cross-border disease spread (Lamprey and Reid,
2004).
In the 1970s and 1980s, the incidence of CBPP in Narok
district was largely reduced by test and slaughter and mass
vaccination. Following the re-emergence of CBPP in Narok
district in 1989/90, mass vaccinations reduced the disease
incidence but vaccination coverage remained low due to
fear of adverse post-vaccination reactions, contributing to
the persistence of the disease to date (Wanyoike, 1999,
2009).
2.3. Description and selection of vaccine and vaccination
attributes to be valued
The choice of vaccine and vaccination attributes was
guided by preferences expressed by farmers in a Par-
ticipatory Rural Appraisal (PRA) carried out in a larger
study (Wanyoike, 2009). The farmers showed differing
preferences for vaccine administration, nature and fre-
quency of vaccination. They were familiar with the aspect
of declining stability after reconstitution of the vaccine.
They also indicated the fear of adverse post-vaccination
reactions in animals and revealed that the vaccinators
charged an unofﬁcial fee per animal. In addition, various
researchers have recommended a safer vaccine, private
and elective vaccination as well as cost shared vaccination
(Thiaucourt et al., 2004; Thomson, 2005; Mariner et al.,
2006). It has also been suggested that the vaccine be mod-
iﬁed by inclusion of a pH buffer in the mycoplasma growth
medium and a pH indicator in the ﬁnal product in order
to increase the stability of the vaccine and introduce end
user assessment of viability of the vaccine (March, 2004).
Costs of vaccination have also been determined in var-
ious vaccinations for CBPP alone or in combination with
other vaccinations. The vaccine attributes that were con-
sidered for valuation were stability, inclusion of a pH
indicator, safety and frequency of administration. The
vaccination attributes that were considered were adminis-
tration of the vaccine and nature of vaccination. Price was
included in the proﬁles to allow for eventual calculation of
WTP.
Stability of a vaccine is the time after reconstitution
for which the vaccine can be used. It is up to 2 h for the
current vaccine but may  be greater than 2 h when the
vaccine is buffered as in the modiﬁed vaccine. The levels of
stability included were therefore 2 h and greater than 2 h.
Safety of the vaccine relates to the proportion of animals
that do not elicit adverse reactions to the vaccine. The
current CBPP vaccine may  elicit post-vaccination reactions
in 1-5% of vaccinated animals (Thiaucourt et al., 2004).
An ideal vaccine should exhibit 100% safety. The levels of
safety included were therefore 95% and 100%. In the CBPP
vaccine, it is increasing acidity that leads to death of the
mycoplasma. This leads to the ineffectiveness of the vac-
cine. The pH indicator is a dye that is placed in the vaccine so
that when the acidity rises, it is indicated by colour change
over a pH range. The current vaccine does not have a pH
indicator. The levels included were therefore inclusion and
non-inclusion of the pH indicator. Frequency refers to the
number of times an animal will be vaccinated per year. If a
vaccine protects for a year then there is need to vaccinate
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animal by the government veterinarian was  KSh 34.60. A
proﬁt margin of KSh 20–40 per animal was  quoted in the
budgets of private veterinarians. The price levels includedFig. 1. Map  of the herds and households surveyed
nly once a year but if it protects for less than a year there
s need to vaccinate at least twice a year. It has also been
bserved that revaccination after 6 months raises vaccine
fﬁcacy from 65% to 95.5% (Wesonga and Thiaucourt,
000). Currently CBPP vaccination in Kenya is once a year.
he levels included were once and twice a year vaccination.
Administration refers to who conducts the vaccination.
he Kenya Government has always administered CBPP vac-
ine in the study area. The Government can choose to
ontinue with this practice or allow private veterinari-
ns to vaccinate while it (the Government) continues with
ts regulatory role. Therefore, the levels of administration
ncluded were government and private vaccination. The
ature of vaccination refers to whether the farmer can
ake decisions on vaccination. CBPP vaccination in Kenyas compulsory but it can also be elective in which the
armer decides whether and when to vaccinate. The lev-
ls of nature of vaccination therefore included compulsory
nd elective vaccination.tudy divisions, Narok South District, Kenya, 2006.
The price was the amount of money to be paid to vac-
cinate each animal during vaccination at the vaccination
site and in cash. In Kenya, CBPP vaccination is offered free
by the government. However, due to ﬁnancial constraints,
an unofﬁcial fee of KSh 10 is charged to facilitate vac-
cine distribution (Wanyoike, 2009). The cost of vaccinating
one animal under a pastoralist setting is USD 0.44 (Kenya
Shillings (KSh) 30 to USD 1.71 (KSh 120) (Twinamasiko,
2002; Tambi et al., 2004).3 The price levels were drawn
from these reports and considered the budgets provided
by government and private veterinarians in Kenya in the
larger study (Wanyoike, 2009). The cost of vaccinating one3 US$ = Kenya Shillings 70 at the time that these studies were carried
out.
ive Veter134 S.W. Kairu-Wanyoike et al. / Prevent
were therefore KSh 10, KSh 30, KSh 50 and KSh 70 (round-
ing down to the nearest 10). The high price of KSh 120 was
not considered as it may  have elicited protest answers as
the price of vaccinations against cattle diseases in the area
do not normally rise above KSh 70.
2.4. Sample size calculation and data collection
The sample size was calculated using a formula for
determining sample sizes for contingent valuation. The for-
mula gave a sample size of 192 households. The sample
size was increased to 232 to cater for a possible 20% non-
response rate (Mitchell and Carson, 1989, p. 364).
There were 14 and nine sub-locations in Mara and
Loita divisions respectively (CBS, 2001). The sub-locations
were characterized ﬁrst on the basis of vaccination, disease
history and sources of livelihood and then one or two con-
trasting sub-locations were selected from each location in
each division. The sampling frame was a list of households
from all the villages in the selected sub-locations which was
obtained from existing lists maintained by local organi-
zations involved in various community-based activities in
the area. Households to be visited were selected randomly
from the lists. Each household visited was geo-referenced
using Geographic Positioning System in order to view the
distribution of the households and for future traceability
(Fig. 1).
Six attributes were presented at two levels each and a
seventh, price, was presented at four levels, amounting to
26 × 4 = 256 different product proﬁles. These would have
been too many for effective valuation by the farmers. To
reduce the number of proﬁles that respondents needed
to rate, an orthogonal design was applied in SPSS Con-
joint 8.0 (Casey, 2009) which selected 16 proﬁles (Table 4)
which was the least number of proﬁles possible which
were needed for rating given the number of attributes
and their levels. The proﬁles were presented in pictorial
form on 16 cards. Data to determine preferences for vac-
cine and vaccination attributes were collected using these
cards. The rating method which applied a ﬁve-point Lik-
ert scale (1 = highly undesirable and 5 = highly desirable)
was used (Likert, 1932). Data on farmer demographics,
socio-economic characteristics, attitudes towards CBPP
and its control as well as herd CBPP risk factors were
collected using pretested semi-structured questionnaires
administered in person by trained enumerators. All the
vaccine and vaccination attributes as well as the valua-
tion procedure were described to the farmers in detail
before valuation while avoiding ‘information overload’ and
other biases that are associated with this methodology
(Mitchell and Carson, 1989). Information on the study
was supplied to the farmers verbally and also through an
information sheet. The research tools had been approved
by the Research Ethics Committee of the University of
Reading.2.5. Analytical methods
By applying a random utility function (Adamowicz et al.,
1994), the utility of the ith livestock farmer selecting theinary Medicine 115 (2014) 130–142
jth vaccine and vaccination proﬁle can be presented in the
following form:
Uij = Vj + ωij, (1)
where U is a stochastic utility function, V is the determinis-
tic component of utility (standard regression function) and
is determined by attributes of the vaccine and vaccination
proﬁle, and ωij is a stochastic error term which accounts for
the inherent shortcomings in observing respondent prefer-
ences. It was  assumed that livestock farmers will be able to
rate product j higher than product l based on the under-
lying utility, if Uij < Uil. Conceptually, the term Vj was  thus
presented as:
Vj = ˇ0 + ˇ1 Stability + ˇ2 Safety + ˇ3 Indicator
+ ˇ4 Administration + ˇ5 Frequency
+ ˇ6 Nature + ˇ7 Price (2)
where Vj represents the ordered response (with 1 = highly
undesirable and 5 = highly desirable) with respect to a set of
vaccine and vaccination attributes (Table 1). Based on the
ordering of the response and the assumption of normal-
ity in ωij, an ordered probit model (OPM) was estimated.
The OPM accounts for the ordinal nature of the response
(dependent) variable (Greene, 2011). The  ˇ values are
marginal utilities arising from a change in the levels of the
respective vaccination attributes.
Vaccine and vaccination attributes were the indepen-
dent variables and were coded as dummy  variables while
price was treated as a continuous variable to allow only
one price coefﬁcient to be used in the WTP  calculation.
The database consisted of 3040 data proﬁles resulting from
190 fully completed questionnaires and 16 proﬁles for each
household. The dependent variables were the ratings of
each of the proﬁles. Data were analyzed using Statistical
Analysis Software (SAS) Version 9.1.3 (SAS Institute Inc.,
Cary, NC, USA). Data analyses were carried out in several
stages.
In the ﬁrst stage, an additive composition model in
which the coefﬁcients are added together rather than mul-
tiplied (multiplicative model) was applied to estimate an
overall WTP  model (Ehmke et al., 2008; Sayadi et al., 2009).
From the coefﬁcients obtained for preferences of vaccine
and vaccination attributes, the WTP  for each attribute j was
calculated as in Eq. (3).
−ˇj/ˇprice (3)
The overall WTP  for vaccine and vaccination was cal-
culated by aggregating the WTPs for all vaccine and
vaccination attributes. As the coefﬁcients were those of
the vaccine and vaccination attributes that the farmers
preferred, the model was  thereafter referred to as ‘pre-
ferred vaccine and vaccination’. In CJA–CVM, WTP  can
be calculated for any proﬁle, presented for valuation or
otherwise so long as the attributes are known (Newman
et al., 2006). WTP  was  also calculated for all the sixteen
proﬁles presented to the farmer and for the current vac-
cine. The proﬁles were then ranked according to WTP  for
them. Further, the additional WTP  resulting from the inter-
action between attributes and household characteristics
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Table  1
Description of the farmer demographic and household characteristic variables used in the regression models, Narok South District, Kenya, 2006.
Variable code Variable description
EDUC Number of years of education of the household head
INC  Household income
CROSS Number of cross-bred cattle in a herd
FAMSIZE Number of members in a household who are dependent on the household head
HRDSIZE Household cattle herd size
TIMES Number of times a herd had suffered CBPP since 1991a
YEARS Number of years since the last incidence of CBPP in the herd
HHNO Number of other households in the homestead
GENDER Sex of household head
AGE Age of the household head
DIV Administrative unit in which the household was  situated
PRIOR Priority given to CBPP with respect to control
LIKE Likelihood of CBPP occurring in the herd
HHSITU Household head’s perception of the household economic situation
SALT Practice of mixing cattle at salt licks
TREAT Practice of treating CBPP cases
OCC Occupation of the household head
GROUP Membership of any household member to an organized group
LEAD Any leadership position of the household head in the community
CLAN Sub-clan of the household head
REAC Adverse post-vaccination reactions to previous CBPP vaccination in the herd
KNOW Household head’s knowledge of CBPP
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sa The year that CBPP returned in the study area.
ere added to the WTP  from the overall model to ascer-
ain the inﬂuence of household characteristics on WTP  for
ttributes (Makokha, 2005) as in Eq. (4).
−(ˇattribute + ˇinteraction)
ˇprice
(4)
In the second stage, individual farmer willingness to pay
as obtained by ﬁrst running individual models for each
armer similar to the ﬁrst overall OPM but using only the
6 observations unique to each farmer (Sayadi et al., 2009).
his was done for all the 190 individual farmer sets of pro-
les. The marginal WTP  for each attribute and the total
TP  for the preferred and current vaccine and vaccination
ttributes for each farmer were obtained in a similar fash-
on to that for the overall model. The proportions of farmers
illing to pay an amount greater than zero and those will-
ng to pay a negative amount were calculated. A negative
TP  emanates from the fact that the WTP  was indirectly
stimated by calculation as the method used in the study
as a stated preferences method, rather than revealed
references method, which may  lead to zero, some posi-
ive values and some negative values. Negative WTP  means
he farmers would require compensation before they can
llow vaccination of their animals. The average amount of
ompensation required per animal was calculated as aver-
ge negative WTP  for both the preferred and the current
accine. The total amount of compensation was calculated
s in Eq. (5).
otal compensation = N × proportion of respondents
with negative WTP  × compensation per animal (5)here N was the total population to be vaccinated.
In the third stage, a backward ﬁtting ordinary least
quares (OLS) model was ﬁtted on WTP  data in orderto demonstrate the household characteristics condition-
ing WTP  (Serneels et al., 2007). The empirical model was
speciﬁed in Eq. (6). The dependent variable WTPi was  the
estimated willingness to pay for CBPP vaccine and vaccina-
tion for the ith household at the time of the survey.
WTPi = ˇ0 + ˇ1 EDUC + ˇ2 INC + ˇ3 CROSS + ˇ4 FAMSIZE
+ ˇ5 HRDSIZE + ˇ6 TIMES + ˇ7 YEARS + ˇ8 HHNO
+ ˇ9 GENDER + ˇ10 AGE + ˇ11 DIV + ˇ12 PRIOR
+ ˇ13 LIKE + ˇ14 HHSITU + ˇ15 SALT + ˇ16 TREAT
+ ˇ17 OCC + ˇ18 GROUP + ˇ19 LEAD + ˇ20 CLAN
+ ˇ21 REAC + ˇ22 KNOW + ε (6)
A description of the independent variables is in Table 1. ˇ0
was the y intercept,  ˇ were the coefﬁcient estimates while
ε was  the error term.
Multicollinearity was tested by checking that the Pear-
son correlation coefﬁcients between any pair of regressors
were less than 0.8 (Kennedy, 1985) and that the conﬁ-
dence intervals of the parameter coefﬁcient estimates were
not too wide (Table 2). The White’s test (White, 1980)
showed that heteroscedasticity was absent (2 = 40.67,
df = 40, p = 0.4407). A natural logarithmic transformation
was carried out to normalize the WTP  and income distri-
butions and residual plots of the ensuing data carried out
to ascertain normality prior to regression (Kennedy, 1985).
There was  high correlation for the disease risk factors of
mixing at grazing, watering and saltlicks. Mixing at saltlicks
was considered to be the more important risk factor accord-
ing to the farmers and was  retained to represent the three in
the OLS model. The measurement of parameter estimates
used SAS statistical software which ﬁxed the independent
variables in a repeated sample model to avoid errors in
ive Veter136 S.W. Kairu-Wanyoike et al. / Prevent
variable assignment as either dependent or independent
and autoregression.
In the fourth stage, assuming a control strategy of
annual vaccination, total social beneﬁts were calculated
as aggregated WTP  which was the product of mean WTP
and the cattle population to be vaccinated (200,000 cat-
tle). The cost of vaccinating one animal was KSh 34.60
(USD 0.49) in the Food and Agriculture Organization of
the United Nations and Government of Kenya (FAO/GOK)
and Wellcome Trust programmes, KSh 45.8 (USD 0.65) for
the Pan African Rinderpest Campaign (PARC) programme
and KSh 72.2 (USD 1.0) in the proposed private pro-
gramme  (Wanyoike, 2009). The beneﬁts were assumed
similar across all programmes and were applied in a bene-
ﬁt cost analysis (Saengsupavanich et al., 2008). The beneﬁt
cost ratio was obtained as in Eq. (7). The analyses were
for control rather than eradication and for only one year
since the short lived potency of CBPP vaccine may  not
allow beneﬁts to be experienced beyond one year hence
discounting was not considered. CBPP eradication given
the current shortcomings in movement control and other
control processes required in the eradication process is not
feasible. The partial budget model (Dijkhuizen et al., 1995)
was applied. The aggregated WTP  was assumed to have
considered total costs saved as avoided outbreak control
costs and total new revenue as avoided production costs
as well as total additional costs of managing adverse post
vaccination reactions.
BCR = Mean WTP
Cost of vaccinating one animal
(7)
Taking the proportion of respondents expressing WTP
for the vaccine and vaccination at the amount indicated and
above as a proxy of the quantity of vaccines ‘purchased’ at
the indicated price (WTP), pseudo-demand curves for the
preferred and current vaccines and vaccination were devel-
oped (Mitchell and Carson, 1989; Ngugi, 2002). Demand
was described as the proportion of farmers willing to pay
an amount greater than zero for the vaccine and vaccina-
tion. From the demand curves, the proportion of farmers
willing to pay the calculated cost of vaccinating one animal
against CBPP alone under joint government programmes
was derived for both the preferred and the current vaccine.
Table 2
Regression coefﬁcient estimates for the preferred vaccine and vaccination attribu
Attribute Coefﬁcient estimate 
Intercept 1.5249 
Greater than 2 h stability 0.0567 
100%  safety 0.8256 
Inclusion of pH indicator in vaccine 0.9507 
Government administration of vaccine 0.2315 
Annual  vaccination 0.0514 
Elective vaccination 0.0542 
Price  (linear) −0.0102 
The coefﬁcient estimate for the alternate attribute (e.g. less than 2 h stability) w
to  allow the use of one price coefﬁcient estimate for calculation of WTP  for each
vaccination attribute and ˇp is the coefﬁcient estimate for price.inary Medicine 115 (2014) 130–142
3. Results
In the surveyed population of 190 farmers, the median
number of years of education of the household head was
zero with a range of 0–14. The median annual household
income was  KSh 335 (range 36–2080 thousand). There
were 0–110 cross-bred cattle in each household with a
median number of zero. Each household had a median
number of 7 (range 1–45) family members. The median
number of other households in a homestead was 3 (range
0–46) and cattle per household was  75 (range 4–600). The
number of times CBPP had been experienced in the herd
since 1991 was zero (range 0–4) while the median number
of years since CBPP had been experienced in the herd was
0 (range 0–47).
Male respondents and young (18–40 years old) respon-
dents contributed 73.7% and 35.3% of total respondents
respectively. Respondents from Mara division formed
66.3% of the total respondents. A proportion of 32.1% of
household heads had an alternative occupation to live-
stock keeping but only 33.2% believed their household
economic situation was  acceptable. Nearly 70.0% of house-
holds mixed their animals at watering, grazing and salt
licks. The proportion of respondents who had some knowl-
edge of CBPP was  87.4%. While 61.6% of the respondents
gave CBPP priority with regard to control and 70.0% saw
a high likelihood of their cattle suffering CBPP, early 38.9%
households treated their animals against CBPP with antimi-
crobials and 53.7% of households had experienced adverse
CBPP post-vaccination reactions in their herds. Member-
ship to an organized group by any of the household
members was observed in 55.3% of households and 37.4%
of household heads were community leaders.
Coefﬁcient estimates of the ordered probit model are
presented in Table 2. It is apparent that overall, the respon-
dents’ preference regarding vaccine and vaccination was
100% vaccine safety, inclusion of a pH indicator in the vac-
cine and administration of the vaccine by the government
(p < 0.0001). From the positive  ˇ coefﬁcients of the other
attributes, overall the respondents also preferred stabil-
ity of the vaccine beyond 2 h after reconstitution, annual
and elective vaccination although this was not statistically
signiﬁcant (p > 0.05).
Table 3 presents the willingness to pay (WTP) for each
attribute level and vaccine proﬁle preferred by the study
tes, Narok South District, Kenya, 2006.
95% CI of coefﬁcient estimates p
1.3963 to 1.6535 <0.0001
−0.0198 to 0.1332 0.1469
0.7469 to 0.9043 <0.0001
0.8709 to 1.0305 <0.0001
0.1549 to 0.3081 <0.0001
−0.0251 to 0.1279 0.1879
−0.0223 to 0.1307 0.1653
−0.0119 to −0.0085 <0.0001
as  the negative of that presented in this table. Price was given linearity
 attribute as −ˇj/ˇp where ˇj is the coefﬁcient estimate for a vaccine of
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Table  3
Mean willingness to pay (WTP) for preferred vaccine and vaccination attributes, Narok South District, Kenya, 2006.
Attribute WTP  KSh (USD) 95% CI of WTP  KSh (USD) % of total WTP
Inclusion of pH indicator 95.12 (1.36) 6.92 to 183.32 (0.10 to 2.62) 44.8
100%  vaccine safety 79.20 (1.13) −16.84 to 175.24 (−0.24 to 2.50) 37.3
Government administration of vaccine 21.45 (0.31) 11.65 to 31.25 (0.17 to 0.45) 10.1
Greater than 2 h vaccine Stability 6.83 (0.10) −14.73 to 28.39 (−0.21 to 0.41) 3.2
Compulsory vaccination 5.05 (0.07) −24.35 to 34.45 (−0.35 to 0.49) 2.4
Annual vaccination 4.82 (0.07) −22.62 to 32.26 (−0.32 to 0.46) 2.3
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Sh is Kenya Shillings: 1 USD = KSh 70.
opulation (preferred vaccine and vaccination). Thus while
he inclusion of a pH indicator contributed the most (44.8%)
o the overall WTP, frequency of once a year vaccination
ontributed the least (2.3%) to overall WTP  for the preferred
accine and vaccination. The mean farmers’ WTP  calculated
rom the overall model was KSh 212.48 (USD 3.03); 95% CI:
Sh 40.00 (USD 0.57)–384.96 (USD 5.50).
The proportion of farmers willing to pay an amount
reater than zero for the preferred vaccine was 66.7% (95%
I: 59.6–73.4) while 33.3% (95% CI: 26.6–40.4) were not
illing to pay (zero and negative amount). Therefore, if
TP  was used as a proxy to measure the expected partic-
pation in vaccination, the average participation expected
as 66.7%. On average, 33.3% of the farmers would need to
e compensated an amount of KSh 1162.62 (USD 13.68);
5% CI: KSh 166.63 (USD 2.38)–KSh 2158.61 (USD 30.84)
er head of cattle. The rate of compensation that would be
equired would be KSh 500 per head of cattle vaccinated
Fig. 2) for the majority of those to be compensated (71.4%;
5% CI: 58.5–81.8%). With a vaccination target of 160,000
attle and an average 108 cattle per herd (in the pastoral
ystem), the total amount of compensation in the study
rea would be KSh 61.39 million (USD 0.88 million).
Table 4 presents the willingness to pay for the 16 vac-
ine and vaccination proﬁles presented to the farmer and
able 4
illingness to pay (WTP) and rank for proﬁles of CBPP vaccine and vaccination, N
Vaccine and
vaccination
proﬁle
Stability
(h)
Safety
(%)
Indicator
included
Administration
of  vaccine
Freq
vacc
Preferred >2 100 Yes GOK Onc
Current 2 95 No GOK Onc
1 >2 95 No Private Onc
2 >2 95 Yes GOK Twi
3 2 95 Yes Private Twi
4 2 100 Yes GOK Onc
5 >2 100 Yes GOK Twi
6 2 100 No Private Twi
7 2 95 Yes GOK Onc
8 2 95 No Private Twi
9 2 100 No GOK Onc
10 2 100 Yes Private Twi
11 >2 100 No Private Onc
12 >2 100 Yes Private Onc
13 >2 95 No GOK Twi
14 >2 100 No GOK Twi
15 2 95 No GOK Onc
16 >2 95 Yes Private Onc
n the price column, – means no price given as the proﬁles were not presented
owever WTP  was  calculated from the individual attribute WTPs since the attrib
0.  Frequency of vaccination was per animal per year. GOK is Government of K
mount of money the farmers were willing to pay.40.00 to 384.96 (0.57 to 5.50) 100.0
additionally the current and preferred vaccine and vacci-
nation proﬁles. For the current vaccine and vaccination,
the farmers were willing to pay on average KSh −71.45
(USD −1.02); 95% CI: KSh −320.53 (USD −4.58)–177.64
(USD 2.54). Only 34.4% (95% CI: 27.6–41.5) of farmers were
willing to pay an amount greater than zero for the current
vaccine and vaccination. The remaining 65.6% (95% CI:
58.5–72.4) were not willing to pay (zero and negative
amount) and would need compensation to vaccinate their
cattle against CBPP using the current vaccine. As with the
preferred vaccine, KSh 500 per head of cattle vaccinated
would be required to compensate the majority (78.4%; 95%
CI: 70.0–85.1) of those not willing to pay (Figure 2). The
average amount of compensation would be KSh 853.72
(USD 12.20); 95% CI: KSh 492.75 (USD 7.04)–KSh 1214.69
(USD 17.35). The total amount of compensation in the
study area would be KSh 90.15 million (USD 1.29 million).
Various household characteristics inﬂuenced the
attribute coefﬁcients by a value equivalent to the inter-
action coefﬁcient as observed in the interaction ordered
probit regression model (Kairu-Wanyoike et al., 2013;
Wanyoike, 2009). Willingness to pay for vaccine and
vaccination attributes was in turn inﬂuenced by these
interactions (Table 5). For instance those with higher
incomes would pay above the average amount for 100%
arok South District, Kenya, 2006.
uency of
ination
Nature of
vaccination
Price KSh
(USD)
WTP KSh
(USD)
Rank
e Elective – 212.48 (3.03) 1
e Compulsory – −71.45 (−1.01) 14
e Elective 50 (0.71) −186.36 (−2.66) 17
ce Compulsory 70 (1.00) 35.12 (0.50) 6
ce Elective 50 (0.71) −21.35 (−0.30) 11
e Compulsory 50 (0.71) 196.24 (2.80) 3
ce Elective 30 (0.43) 197.19 (2.81) 2
ce Elective 70 (1.00) −45.21 (−0.64) 13
e Elective 10 (0.14) 34.43 (0.49) 7
ce Compulsory 30 (0.43) −207.11 (−2.96) 18
e Elective 30 (0.43) 10.22(0.14) 9
ce Compulsory 10 (0.14) 140.31 (2.00) 5
e Compulsory 10 (0.14) −24.27 (−0.34) 12
e Elective 70 (1.00) 162.33 (2.31) 4
ce Elective 10 (0.14) −150.21 (−2.14) 15
ce Compulsory 50 (0.71) 1.041 (0.16) 8
e Compulsory 70 (1.00) −151.09 (−2.16) 16
e Compulsory 30 (0.43) 0.11 (0.00) 10
 to the farmers since they were not selected by the orthogonal design.
utes of the proﬁles were known. KSh is Kenya Shillings and 1 USD = KSh
enya. Rank was  for the vaccine and vaccination proﬁle according to the
138 S.W. Kairu-Wanyoike et al. / Preventive Veterinary Medicine 115 (2014) 130–142
nd prefeFig. 2. Proportion of farmers to be compensated to allow use of current a
vaccine safety, inclusion of a pH indicator in the vaccine
and government vaccination. Also male heads of house-
holds, respondents from Mara division, those who  had
experienced CBPP in their herds many times or saw a high
likelihood of CBPP occurring in their herds were willing to
pay a higher than average amount for 100% vaccine safety.
The most parsimonious model resulting from a back-
ward ﬁtting OLS on WTP, farmer demographics and
household characteristics data is presented in Table 6.
WTP  for vaccine and vaccination proﬁles was signiﬁcantly
inﬂuenced by the attitude about household economic sit-
uation (p = 0.0078), presence of cross-breds in the herd
Table 5
Willingness to pay (WTP) resulting from the interaction model, in Narok South D
Interaction 
Income*100% safety of the vaccine 
Income*inclusion of a pH indicator in the vaccine 
Male  gender*100% safety of the vaccine 
Age*inclusion of a pH indicator in the vaccine 
Likelihood of CBPP in herd*100% safety of the vaccine 
Mixing of cattle at salt lick*100% safety of the vaccine 
Treat  against CBPP*inclusion of a pH indicator in the vaccine 
Mara  division*100% safety of the vaccine 
Years  ago since CBPP was experienced*100% safety of the vaccine 
Number of times CBPP experienced*100% safety of the vaccine 
Herd  size*Government administration of the vaccine 
In the interaction column, * means interaction. Interaction is the inﬂuence of on
factor depend on the level of another.
Table 6
Effect of household characteristics on willingness to pay (WTP) for vaccination N
Variable Coefﬁcient estimate 
Intercept 7.7375 
Gender 0.1196 
Household situation −0.1765 
Crosses −0.0203 
Treat  0.1356 
Education 0.0164 
Group  0.0499
Years  −0.0118 
Income  0.0208 
The factors inﬂuencing WTP  were determined through a backward ﬁtting ordina
important, only those that signiﬁcantly inﬂuenced WTP  were included in this ou
which  were retained for the purpose of discussion.rred CBPP vaccine and vaccination, Narok South District, Kenya, 2006.
(p < 0.0001), practice of treating animals against CBPP
(p = 0.0432), education (p = 0.0251) and the number of years
since clinical CBPP had been experienced in the herd
(p = 0.0375). Although the inﬂuence of income was  not sig-
niﬁcant (p = 0.5761), it was positively correlated to WTP.
Those who treated against CBPP and the educated were
willing to pay for vaccination (positive  ˇ estimates). Unex-
pectedly, those who perceived their household situation
to be acceptable and those with crosses in their herds were
less willing to pay for vaccination (negative  ˇ estimates). As
expected, those who  had experienced CBPP many years ago
(not recently) were less willing to pay for CBPP vaccination.
istrict, Kenya, 2006.
WTP  (KSh) WTP  (USD) p
93.75 1.34 <0.001
100.61 1.44 0.005
143.97 2.06 <0.001
139.69 2.00 0.006
118.57 1.69 0.013
169.18 2.42 0.001
134.32 1.92 0.030
109.87 1.57 0.008
83.39 1.19 0.044
103.81 1.48 0.007
22.52 0.32 0.030
e attribute on another. Interaction effect exists when differences in one
arok South District, Kenya, 2006.
95% CI of coefﬁcient estimate p
6.81–8.67 <0.0001
−0.02 to 0.26 0.0947
−0.30 to −0.05 0.0078
−0.03 to −0.01 <0.0001
0.01 to 0.27 0.0432
0.00 to 0.03 0.0251
−0.07 to 0.17 0.4292
−0.02 to 0.00 0.0375
−0.05 to 0.09 0.5761
ry least squares (OLS) regression model. From 22 factors assumed to be
tput (most parsimonious model) except for the case of gender and group
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(demand curve for preferred vacci
ig. 3. Cumulative proportion of respondents willing to pay for current a
A demand curve can be constructed for only those with
TP  equal to zero and above. A pseudo-demand curve was
onstructed for these respondents. The pseudo demand
urve represented the share of households that were will-
ng to pay the amount indicated and above up to the next
mount (Fig. 3). The proportion of those with WTP  above
ero who were willing to pay the calculated cost of vacci-
ation of KSh 34.60 was 59% for the preferred vaccine and
accination and 27% for the current vaccine and vaccina-
ion.
Table 7 shows the social beneﬁt to cost ratios of the var-
ous vaccination programmes. The BCRs using aggregated
TP  as beneﬁts ranged from 2.9 to 6.1 depending on vacci-
ation programme indicating that vaccination against CBPP
as economically worthwhile for all programmes.
. Discussion
The mean farmers’ willingness to pay for the preferred
accine and vaccination was KSh 212.48. When compared
ith the calculated cost of vaccination of KSh 34.6 by the
overnment and KSh 72.2 by the private sector, this mean
TP  can be considered a high price especially because
his community is generally poor (Wanyoike, 2009). How-
ver, the wide conﬁdence interval indicates a high level of
ncertainty and further studies are needed. It nevertheless
emonstrates the desire by the community for a better vac-
ine. Similar scenarios of high WTP  premiums for goods or
ervices have been noted in other WTP  studies involving
eveloping African countries (Frick et al., 2003; Rheingans
able 7
ocial beneﬁt to cost of vaccination under various programme costs, in Narok Sou
Wellcome Trust Project PAR
Cost of vaccinating one animal (KSh) 34.6 45.8
Total  cost of vaccination (Million KSh) 6.9 9.2
Total  social beneﬁts (Million KSh) 42.5 42.5
Net  beneﬁts (Million KSh) 35.6 33.3
Social  beneﬁt cost ratio 6.1 4.6
ARC, Pan African Rinderpest Campaign; FAO, Food and Agriculture Organization
1  USD = KSh 70).demand curve for current vaccine
rred CBPP vaccine and vaccination, Narok South District, Kenya, 2006.
et al., 2004; Ehmke et al., 2008). The negative WTP  of an
average KSh −71.45 for the currently used vaccine and vac-
cination shows that on average, farmers were not willing
to pay for the current vaccine and vaccination.
A WTP  above zero by 66.7% of farmers is similar to
the actual observation that in past studies in the study
area, CBPP vaccination coverage using the current vaccine
reached a maximum of 60% (Wanyoike, 1999). Ultimately,
even if the vaccine and vaccination were free and had the
desired attributes vaccination coverage may  not rise above
66.7% which might not be sufﬁcient to interrupt transmis-
sion of CBPP in a herd. This means that including all the
preferred vaccine and vaccination attributes may  not nec-
essarily lead to optimal participation in CBPP vaccination.
Farmers may  also have other reasons for rejecting vac-
cination other than undesirable vaccine and vaccination
attributes. Possible reasons are inadequate knowledge of
how vaccines work and their full beneﬁts in spite of hav-
ing knowledge on the disease, inappropriate attitudes and
perceptions about CBPP and its control as well as wrong
timing of vaccination (Wanyoike, 2009). Heffernan et al.
(2008) in their study on livestock vaccine adoption among
poor farmers in Bolivia demonstrated that membership of a
farmer to an organized group in the community and knowl-
edge transfer through social networks can increase vaccine
uptake.Nearly one-third and two-thirds of farmers required
compensation to accept the preferred and current vac-
cine and vaccination respectively. Other studies have also
elicited need for compensation to use a good or service
th District, Kenya, 2006.
C FAO/GOK Private without proﬁt Private with proﬁt
 34.6 61.0 72.2
 6.9 12.2 14.4
 42.5 42.5 42.5
 35.6 30.3 28.1
 6.1 3.5 2.9
 of the United Nations; GOK, Government of Kenya; KSh, Kenya Shillings
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(Ngugi, 2002; Frick et al., 2003; Rheingans et al., 2004). The
implication is that even if vaccine and vaccination were
offered free of charge, these farmers would not vaccinate
their animals unless they are compensated. However, as
the WTP  was calculated rather than given directly by the
farmers, it was not possible to query the respondents on
it. The total amounts of compensation required for both
the preferred and the current vaccine and vaccination were
high and compensation may  not be feasible especially if
vaccination is carried out more than once a year. Aware-
ness creation in farmers on impact of CBPP and its control
by vaccination as well as how CBPP vaccine works, coupled
with dialogue with farmers to persuade them to vaccinate,
would probably increase vaccination coverage.
One CBPP infected herd in an area can lead to infec-
tion of other herds (high negative externalities associated
with CBPP). In addition, CBPP control in several herds in an
area can lead to control even for those who do not vacci-
nate (high positive externalities associated with its control)
(Rushton and Leonard, 2008). Due to these phenomena, the
current vaccine limitations and the fact that private veteri-
nary practitioners in Kenya are not willing to operate in
pastoralist areas as well as the limited WTP  demonstrated
in this study (Wesonga and Thiaucourt, 2000; Thiaucourt
et al., 2004; Woodford, 2004), CBPP remains essentially a
disease whose control requires public funds. Consequently,
market failure is likely to be encountered in delivering the
CBPP vaccine by the private sector (McLeod and Wilsmore,
2002). A proportion of farmers were willing to pay for vac-
cination using either the preferred or the current vaccine at
the calculated cost of KSh 34.60 for publicly administered
vaccine. The proportion would be lower for private vac-
cination. A farmer may  be unwilling to pay because their
incomes are low or their expenditures in other areas are
high. The current scenario in vaccination against CBPP in
Kenya is that it is compulsory, administered by the govern-
ment and fully subsidized (Kajume, 1999). This obviously
has not ensured optimal CBPP vaccination. This study has
demonstrated that while some farmers are willing to pay,
some are not. In addition, some farmers may  prefer private
to government vaccination (Kairu-Wanyoike et al., 2013).
Elective vaccination can be allowed with the farmer meet-
ing part or full cost of vaccination for the proportion that
would like to pay but compulsory, fully subsidized vaccina-
tion retained for those not willing to pay. It has already been
stated that CBPP is essentially a public good disease. There-
fore, if the private sector were to vaccinate against CBPP,
subsidization is important to achieve the required cover-
age and to avoid market failure. The government would
need to synchronize and regulate vaccination in all sce-
narios (elective and compulsory) and to change policy on
CBPP vaccination to accommodate elective and privatized
vaccination in order to achieve the optimal vaccination cov-
erage.
Farmers with higher incomes would pay more to have a
better vaccine and for government administration of vac-
cine probably in the hope of getting better returns on their
investment. The young would pay more for inclusion of an
indicator in the vaccine probably because they would more
readily try something new. Farmers who saw a higher like-
lihood of their animals contracting CBPP, those who  hadinary Medicine 115 (2014) 130–142
experienced CBPP many times as well as those from Mara
division would pay more for a safer vaccine probably due to
their experiences with adverse post vaccination reactions.
As expected, WTP  was positively inﬂuenced by education
as was  also observed in other studies (Ngugi, 2002; Frick
et al., 2003; Rheingans et al., 2004) and those who had
experienced CBPP many years ago (not recently) were less
willing to pay probably because of perceived low risk of
the disease. However, Wanyoike (2009) has demonstrated
that it is beneﬁcial to vaccinate against CBPP even if the
incidence were as low as 1.1% and so these farmers should
be encouraged to vaccinate. It is possible that participation
in vaccination can be sustained by taking advantage of the
cooperation of those with characteristics which positively
inﬂuenced WTP  and persuading those with characteristics
which negatively inﬂuenced WTP  to vaccinate.
The unexpected observations that households which
perceived their household situation to be acceptable and
that those with cross-bred cattle in their herds were less
willing to pay is likely to be because of a type I error due to
the stepwise automated ﬁtting approach although this was
controlled by checking that there were no large variations
in the coefﬁcient estimates and p values during addition
and removal of parameters to the model. Alternatively,
households which perceived their household situation to
be acceptable may  not have considered cattle keeping as
very important in their livelihoods. Likewise, it is possible
respondents may  have considered cross-breds to be more
resistant to CBPP.
About half (53.7%) of farmers had experienced adverse
post-vaccination reactions in at least one animal in their
herds (Wanyoike, 2009). Usually this may  be unacceptable
to some farmers who  may  own  only a few animals. In some
cases, it may  the best producer in the herd whose produc-
tion has been reduced even if temporarily (Wanyoike, 1999,
2009). In addition, in the overall preference model, farm-
ers had a strong preference for 100% safety of the vaccine
(Kairu-Wanyoike et al., 2013). However, the experience of
post-vaccination reactions in their herds did not signiﬁ-
cantly inﬂuence their willingness to pay for vaccine and
vaccination. This was consistent with the attitude in some
farmers that in spite of the reactions, their animals were
protected anyway (Wanyoike, 2009). Though membership
to an organized group inﬂuenced the WTP  positively, this
was  not signiﬁcant. Indeed, information offered by such
groups did not include information on CBPP and its control
(Wanyoike, 2009). The possibility of offering information
about CBPP and its control through organized groups can
be explored.
The calculated BCRs showed that it is economically ben-
eﬁcial to vaccinate against CBPP. The BCRs were lower
than but comparable to those observed in the same study
area as this current study (5.64–9.60) which used avoided
production losses and costs saved as beneﬁts in tradi-
tional beneﬁt cost analysis (Wanyoike, 2009). Thus there
was  some agreement in results while using two  different
study methodologies. This justiﬁes the use of aggregated
WTP  in a beneﬁt cost analysis particularly because mea-
suring avoided losses in an animal population in pastoral
communities can be difﬁcult, time consuming and expen-
sive. It is generally assumed that in valuing beneﬁts using
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ggregated WTP, the farmer may  consider beneﬁts which
re not normally quantiﬁed in traditional BCA (intangible
ocial beneﬁts) and that revenue forgone such as that due
o adverse reactions to ring vaccinations after outbreaks
ill be avoided. Consequently, if the farmers fully under-
tand the impact of CBPP and the value of vaccination in
ontrol, beneﬁts valued this way should be higher than
hen avoided losses and costs saved are used (Rheingans
t al., 2004). However in this case they were lower probably
ecause while widespread vaccination provides indirect
eneﬁts through herd immunity effects, this may  not be
aptured by the WTP  of individual farmers who do not
onsider the beneﬁts experienced by other farmers. Com-
ensation for farmers not willing to vaccinate against CBPP
as way above the calculated beneﬁts of vaccination and
ay  cause vaccination to be uneconomical.
To the best of our knowledge, this is the ﬁrst study to
easure WTP  for CBPP vaccine and vaccination. It is also the
rst study that has used CJA–CVM in the ﬁeld of veterinary
edicine although the method has been used in other ﬁelds
Ehmke et al., 2008; Sayadi et al., 2009). Other formats that
an be used to elicit WTP  are revealed preference methods
uch as open ended, payment cards, bidding games and
ichotomous choice methods (Brown, 2005).
The major shortcoming of revealed preference is that
t puts the respondent through the difﬁcult task of formu-
ating a price and can lead to protest or strategic answers
here the farmer refuses to give a price or gives unrealis-
ic answers (Mitchell and Carson, 1989). Stated preference
ethods such as CJA–CVM minimize these problems. On
he other hand the stated preference method requires the
alculation of WTP  given the responses which makes it dif-
cult to query the farmers about the calculated WTP  and
an also result in outlier and negative WTPs. However, it
ives a clear indication of the level of demand for the vac-
ine. In both stated and revealed preference methods, the
armers may  not pay what they indicate they will pay. If an
ffordable benchmark price is needed, then the incomes
nd expenditures of the farmers need to be examined to
etermine ability to pay.
In this study, stated preference was used because the
armers were not familiar with formulating prices for vac-
ine and vaccination since currently the vaccine is offered
ree of charge. In addition, the study objective was to mea-
ure preferences and WTP  in a single step to reduce costs
hich is best done using CJA–CVM. A shortcoming of this
tudy was that the ability to pay by the respondents was  not
uantiﬁed due to data limitations and can be considered in
urther research.
Narok South district was chosen because it was  assumed
hat the high and long presence of the disease made the
armers aware of the disease and would respond to the
tudy better than farmers who are not familiar with the
isease. It is possible that in an area of low CBPP incidence,
he preferred vaccine and vaccination attributes as well as
TP  may  have been different. Although the results may
e limited to Narok South District, the study provides use-
ul information on preferences and WTP  and provides a
odel for CBPP WTP  studies in other districts in Kenya
nd other countries experiencing CBPP as well as for other
iseases.inary Medicine 115 (2014) 130–142 141
5. Conclusions
The WTP  for preferred vaccine and vaccination was
high but since there was  high level of uncertainty, further
WTP  studies are needed. About two-thirds and one-third
of farmers were willing to pay for the preferred vaccine
and vaccination and the current vaccine and vaccination
respectively. The inclusion of a pH indicator and abso-
lute safety contributed most to willingness to pay. There is
need for formulation of a vaccine and vaccination with the
preferred attributes. One-third and two-thirds of farmers
would require compensation to allow vaccination of their
cattle with the preferred and current vaccine and schedule.
However, since the amounts of compensation were high,
there should be awareness creation on working of vaccines
and persuasion of farmers to vaccinate. Willingness to pay
for vaccine and vaccination attributes and for the entire
proﬁles was inﬂuenced by various farmer demographics
and household characteristics. Vaccination against CBPP
was economically worthwhile using all programmes inves-
tigated and should be supported for control of CBPP. Among
those willing to pay for vaccine and vaccination, nearly
half were willing to pay at the calculated cost for publicly
administered vaccine. About a quarter were willing to pay
this amount for the current vaccine and vaccination. Elec-
tive vaccination in which the farmers bear part of or the
full cost of vaccination can be allowed for the proportion
of farmers that would like to pay and compulsory, fully
subsidized vaccination retained for those not willing to pay.
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